Ross Clark is a leader writer and columnist who has written for The Spectator for three decades. His books include Not Zero, The Road to Southend Pier, and Far From EUtopia: Why Europe is failing and Britain could do better
Oh, do make your mind up. Is snow in Britain going to be eradicated for good due to climate change – or are we going to be plunged into arctic conditions as climate change breaks down North Atlantic currents and sets up blocking patterns which suck frost down from the North Pole for weeks on
In spite of the approval of one vaccine and the likely approval of at least two others, the government seems determined to push ahead with ‘operation moonshot’ — mass community testing along the lines of that being trialled in Liverpool. That is astonishing, not least because of the cost — put at £100 billion in
Much has been made of the speed at which UK regulators have approved the Pfizer-BioNTech vaccine for use in Britain. But will being first to approve the drug make much difference anyway, given the news this morning that Pfizer is having some difficulty rolling out the vaccine? This morning the business secretary Alok Sharma confirmed that the
As a case study of how assertion can end up sounding like fact, I thoroughly recommend the Lancet’s report this morning claiming that the number of heat-related deaths globally has more than doubled in the past 20 years — and in particular the reporting of the story on the Today programme this morning. The message
Britain, we learned this morning, has become the first country in the world to approve the Pfizer/BioNTech vaccine, which is likely to be deployed from Monday onwards. Is Britain being reckless, or are other countries dragging their heels? The first point to make is that, however tempting though it may be to think so, it
Fancy buying half a flat, paying 100 per cent of the maintenance and the cost of putting right a developer’s shoddy work? Therein lies the great scandal at the heart of shared ownership, the government scheme which BBC Panorama exposed last week but which I others were writing about over a decade ago. Shared ownership
Beware data that is released on the eve of a Commons vote on lockdown restrictions. That was the lesson of the graph presented by Sir Patrick Vallance at the Downing Street press briefing on 31 October, which included a scenario of 4,000 deaths a day by December unless drastic action was taken. The figure quickly fell apart when
I’ve never worked out why anyone would want to buy an outfit over the internet without first seeing it in the flesh and trying it on. I know my wife does it all the time — although the constant piles of parcels by the door, full of stuff waiting to be sent back whence it
Assessing the number of Covid deaths has been notoriously difficult throughout the pandemic. Over the summer, English figures were revised down by more than 5,000 after researchers at Oxford University discovered a flaw in the way Public Health England was registering deaths. Another route for assessing the mortality of Covid is to look at excess deaths — while
Just what is the essential difference between our two main political parties? Certainly not their respective attitudes towards fiscal prudence; the thing which used to provide clear blue water between the two. Now we have two parties which don’t give a damn about public debt, who think that they can spend willy-nilly and that something,
What will the new map of tiers look like when England exits lockdown next week? It certainly won’t be the same system we left behind when we went into lockdown on 5 November. For one thing, we have been told that restrictions are tightening and that more areas will be shunted into Tier 3. The epicentres
We have become used to Mondays bringing good news on the vaccine front. But the publication of interim results from the Astra Zeneca/Oxford University vaccine – AZD1222 – will certainly please the UK government. Not merely because this is the home-grown option and we have already ordered 100m shots, but because, shot for shot, it
Remember ‘immunity passports’? Back in April they were floated as a possible means by which we could all get back to a normal life. We could be tested for antibodies to SARS-CoV-2 – the virus which causes Covid-19 – and, if we tested positive, we could be allowed to go about our business. The presumption
There is nothing wrong with the general direction of policy contained within the government’s ten point plan to cut carbon emissions, announced today. Who doesn’t want clean energy and more energy-efficient homes and vehicles? The problem is the perverse target which lies at its heart: the legally-binding demand, laid down in the Climate Change Act,
Now that we seem to have two Covid-19 vaccines that work, do we really need Operation Moonshot, the government’s programme to test 10 million people a day by early next year? It’s a poignant question, not least because of the extraordinary sums which appear to have been committed to it: briefing documents leaked to the
Another week, another set of preliminary results from a Covid-19 vaccine trial. This time it is the Moderna vaccine candidate, mRNA-1273. And, to judge by the figures put out by the company this morning, it has outdone the Pfizer vaccine in its efficacy. Out of the 30,000 people involved in the phase three trial (half
If the first victim of war is truth, then the first victim of Covid-19 was a sense of proportion. The pandemic continues to dominate the news every waking hour, as well as continuing to restrict our lives in ways not seen since wartime – in some ways even more severely. Yet how many people even
How much has this week’s ructions in Downing Street been influenced by the Prime Minister’s decision, two weeks ago, to call for a new 28 day lockdown – and the subsequent questions asked of the data to justify it? On the one side are the 50 or so Conservative MPs who have joined the Covid
So is this the big turning point? Markets certainly seem to think so. No sooner had news broken that the vaccine being developed by Pfizer and German firm BioNTech is 90 per cent effective, the FTSE surged by 5 per cent. Given that the US Food and Drug Administration (FDA) has suggested that any vaccine
